Drugs like Ozempic might lower cancer risk

Meghan Rosen is a senior writer who reports on the life sciences for Science News. She earned a Ph.D. in biochemistry and molecular biology with an emphasis in biotechnology from the University of California, Davis, and later graduated from the science communication program at UC Santa Cruz.

→ Continue reading at Science News

More from author

Related posts

Advertisment

Latest posts

A ClaimTek Medical Billing Franchise has Multiple Revenue Stream Potential

ClaimTek Systems is a strategic gateway to the rapidly growing medical billing sector—a field forecasted to more than double in size by 2030 and...

We Built a 7-Figure Business Without a Single Investor — Here’s Why Saying No to VC Was Our Smartest Move

Opinions expressed by Entrepreneur contributors are their own. You've heard this story before: a couple of college kids launch a startup from...

Is AI the Future of PR, or Will Emotional Intelligence Win Out?

Opinions expressed by Entrepreneur contributors are their own. I was recently asked, "What trends should we be watching out for in terms...